Other
OSC
OSC is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
2
67%
Ph not_applicable
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
withdrawn133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
NCT04084431
completedearly_phase_1
Heart Rate Variability Biofeedback in Older Adults
NCT05902286
unknownearly_phase_1
Heart Rate Variability Biofeedback Following Traumatic Brain Injury
NCT05913505
Clinical Trials (3)
Showing 3 of 3 trials
NCT04084431Not Applicable
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
NCT05902286Early Phase 1
Heart Rate Variability Biofeedback in Older Adults
NCT05913505Early Phase 1
Heart Rate Variability Biofeedback Following Traumatic Brain Injury
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3